Worth reading
48Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
6930
Shares (693 stock acquisition rights × 10 shares per right)Wording
Conditional
How definitive the wording is.Details of issuance or disposal
Issuance of stock acquisition rights as stock-based stock options for Directors
Who receives how much
Up to 6,930 common shares (693 stock acquisition rights, 10 shares per right)
5 directors of the Company, 693 rights
The lower thin line represents the existing number of shares to which these shares will be added.
Amount based on the fair value calculated using the Black-Scholes model on the allotment date of the stock acquisition rights (the specific amount per right is Not disclosed)
Amount of funds to be raised
Total payment amount: Not disclosed; estimated net proceeds: Not disclosed (the payment amount will be offset against compensation receivables)
Total Stock-Based Compensation
The amount payable for the stock acquisition rights will be offset against compensation receivables. The specific amount of monetary compensation receivables is Not disclosed.
Terms of the stock acquisition rights
Exercise price
¥1 per share. The existence of an adjustment provision and the adjustment floor are Not disclosed.
Exercise period
From 4 August 2026 to 3 August 2056
Number of Stock Acquisition Rights
Total number issued: 693 rights. Number of unexercised rights: Not disclosed.
Reason for acquisition without consideration
If, before exercise, a holder of the stock acquisition rights becomes unable to exercise them under the exercise conditions or the provisions of the stock acquisition rights allotment agreement. Also, if a proposal seeking approval for a merger or other organizational restructuring in which the Company is the disappearing company is approved.
Categories and Number of Persons Covered
5 directors of the Company, 693 rights
Basis for determining the amount to be paid
Amount based on the fair value calculated using the Black-Scholes model on the allotment date of the stock acquisition rights. The periods used for the reference closing price and average share price, and the discount and premium rates are Not disclosed.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of stock acquisition rights as stock-based stock options for Directors |
| Number of shares to be issued or disposed of | Up to 6,930 common shares (693 stock acquisition rights, 10 shares per right) |
| Issue price and disposal price | Amount based on the fair value calculated using the Black-Scholes model on the allotment date of the stock acquisition rights (the specific amount per right is Not disclosed) |
| Amount of funds to be raised | Total payment amount: Not disclosed; estimated net proceeds: Not disclosed (the payment amount will be offset against compensation receivables) |
| Intended allottee | 5 directors of the Company, 693 rights |
| Basis for determining the amount to be paid | Amount based on the fair value calculated using the Black-Scholes model on the allotment date of the stock acquisition rights. The periods used for the reference closing price and average share price, and the discount and premium rates are Not disclosed. |
| Exercise price | ¥1 per share. The existence of an adjustment provision and the adjustment floor are Not disclosed. |
| Exercise period | From 4 August 2026 to 3 August 2056 |
| Number of Stock Acquisition Rights | Total number issued: 693 rights. Number of unexercised rights: Not disclosed. |
| Reason for acquisition without consideration | If, before exercise, a holder of the stock acquisition rights becomes unable to exercise them under the exercise conditions or the provisions of the stock acquisition rights allotment agreement. Also, if a proposal seeking approval for a merger or other organizational restructuring in which the Company is the disappearing company is approved. |
| Categories and Number of Persons Covered | 5 directors of the Company, 693 rights |
| Total Stock-Based Compensation | The amount payable for the stock acquisition rights will be offset against compensation receivables. The specific amount of monetary compensation receivables is Not disclosed. |
Items this document does not state (16)
Total issue valueEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To promote the sustainable growth of corporate value, namely management with greater awareness of the share price.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.